Inventor · disambiguated record
Thomas T. Tibbitts
Also filed as: TIBBITTS THOMAS · TIBBITTS THOMAS T
22 granted patents·12 pending applications·32 citations·filing 2003–2023
92Inventor score
Files withINFINITY PHARMACEUTICALS INC12BEHNKE MARK L4GOLDFINCH BIO INC4PINTEX PHARMACEUTICALS INC4CASTRO ALFREDO C3
Top patents by PatentIndex Score
34 records- 0187US7947663B2Inhibitors of fatty acid amide hydrolaseINFINITY PHARMACEUTICALS INC·Filed 2007·Granted May 24, 2011·6 cites·12 claims
- 0286US7842815B2Compounds and methods for inhibiting the interaction of BCL proteins with binding partnersINFINITY PHARMACEUTICALS INC·Filed 2006·Granted Nov 30, 2010·5 cites·3 claims
- 0382US8349814B2Inhibitors of fatty acid amide hydrolaseINFINITY PHARMACEUTICALS INC·Filed 2011·Granted Jan 8, 2013·3 cites·17 claims
- 0481US8629125B2Inhibitors of fatty acid amide hydrolaseINFINITY PHARMACEUTICALS INC·Filed 2012·Granted Jan 14, 2014·3 cites·18 claims
- 0581US8546432B2Tetrazolones as inhibitors of fatty acid synthaseBAHADOOR ADILAH·Filed 2011·Granted Oct 1, 2013·7 cites·35 claims
- 0677US8329675B2Inhibitors of fatty acid amide hydrolaseADAMS JULIAN·Filed 2011·Granted Dec 11, 2012·2 cites·31 claims
- 0775US9346769B2Tetrazolones as inhibitors of fatty acid synthaseINFINITY PHARMACEUTICALS INC·Filed 2013·Granted May 24, 2016·2 cites·57 claims
- 0875US9108989B2Inhibitors of fatty acid amide hydrolaseINFINITY PHARMACEUTICALS INC·Filed 2013·Granted Aug 18, 2015·1 cites·16 claims
- 0973US8461191B2Compounds and methods for inhibiting the interaction of BCL proteins with binding partnersCASTRO ALFREDO C·Filed 2010·Granted Jun 11, 2013·1 cites·38 claims
- 1069US2024226328A9Modulation of gene expression for disease treatmentDOGODAN THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1168US8765735B2Isoxazolines as inhibitors of fatty acid amide hydrolaseBEHNKE MARK L·Filed 2010·Granted Jul 1, 2014·1 cites·30 claims
- 1267US12466834B2Imidazodiazepinediones and methods of use thereofGFB ABC LLC·Filed 2023·Granted Nov 11, 2025·0 cites·17 claims
- 1366US8450350B2Triazoles as inhibitors of fatty acid synthaseBAHADOOR ADILAH·Filed 2011·Granted May 28, 2013·1 cites·37 claims
- 1459US7928244B2Compounds and methods for inhibiting the interaction of BCL proteins with binding partnersINFINITY DISCOVERY INC·Filed 2007·Granted Apr 19, 2011·0 cites·37 claims
- 1557US2015344503A1Inhibitors of fatty acid amide hydrolase, methods of treatment and methods of preparing sameINFINITY PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 1656US8178690B2Compounds and methods for inhibiting the interaction of BCL proteins with binding partnersCASTRO ALFREDO C·Filed 2011·Granted May 15, 2012·0 cites·15 claims
- 1754US8609706B2Compounds and methods for inhibiting the interaction of BCL proteins with binding partnersCASTRO ALFREDO C·Filed 2012·Granted Dec 17, 2013·0 cites·14 claims
- 1853US2015099738A1Isoxazolines as inhibitors of fatty acid amide hydrolaseINFINITY PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1951US11623930B2Imidazodiazepinediones and methods of use thereofGOLDFINCH BIO INC·Filed 2019·Granted Apr 11, 2023·0 cites·10 claims
- 2050US9630979B2Inhibitors of monoacylglycerol lipase and methods of their useINFINITY PHARMACEUTICALS INC·Filed 2012·Granted Apr 25, 2017·0 cites·22 claims
- 2149US2013243727A1Triazoles as inhibitors of fatty acid synthaseINFINITY PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 2249US2005004024A1Methods of treating Pin1 associated disorders by covalent modification of active site residuesPINTEX PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 2349US2017119734A1Tetrazolones as inhibitors of fatty acid synthaseINFINITY PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 2447US2006106077A1Pin1-Modulating compounds and methods of use thereofPINTEX PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 2545US8957049B2Inhibitors of fatty acid amide hydrolaseBEHNKE MARK L·Filed 2010·Granted Feb 17, 2015·0 cites·21 claims
- 2643US9149465B2Isoxazolines as inhibitors of fatty acid amide hydrolaseBEHNKE MARK L·Filed 2010·Granted Oct 6, 2015·0 cites·10 claims
- 2742US2005049267A1Pin1-modulating compounds and methods of use thereofPINTEX PHARMACEUTICALS INC·Filed 2003·Application pending·0 cites
- 2842US2004214872A1Pin1-modulating compounds and methods of use thereofPINTEX PHARMACEUTICALS INC·Filed 2003·Application pending·0 cites
- 2941US12435078B2Pyridazinones and methods of use thereofGOLDFINCH BIO INC·Filed 2018·Granted Oct 7, 2025·0 cites·10 claims
- 3041US2021115036A1Azaindoles and methods of use thereofGOLDFINCH BIO INC·Filed 2018·Application pending·0 cites
- 3141US2015368278A1Inhibitors of fatty acid amide hydrolaseINFINITY PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 3240US2020377505A1Benzimidazoles and aza-benzimidazoles, and methods of use thereofGOLDFINCH BIO INC·Filed 2018·Application pending·0 cites
- 3334US8927551B2Isoxazolines as inhibitors of fatty acid amide hydrolaseBEHNKE MARK L·Filed 2010·Granted Jan 6, 2015·0 cites·45 claims
- 3432US9062116B2Anti-fatty acid amide hydrolase-2 antibodies and uses thereofALI JANID A·Filed 2010·Granted Jun 23, 2015·0 cites·21 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →